Literature DB >> 1982760

Corneal and conjunctival/scleral penetration of p-aminoclonidine, AGN 190342, and clonidine in rabbit eyes.

D S Chien1, J J Homsy, C Gluchowski, D D Tang-Liu.   

Abstract

The ocular penetration pathways of three alpha 2-adrenergic agents (p-aminoclonidine, AGN 190342, and clonidine) were investigated in rabbits both in vitro and in vivo. The corneal permeabilities of the compounds correlated positively with their octanol/water distribution coefficients. The ocular drug absorption via corneal and conjunctival/scleral penetration routes was evaluated separately after drug perfusion in vivo. In most cases, the corneal route was the major pathway for the intraocular drug absorption. However, the conjunctival/scleral penetration pathway was the predominant pathway for the delivery of p-aminoclonidine, the least lipophilic compound among the three drugs, to the ciliary body. The drug concentration in the iris was contributed mainly by the corneal route and correlated well with drug lipophilicity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1982760     DOI: 10.3109/02713689008997579

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  13 in total

1.  Influence of format on in vitro penetration of antibody fragments through porcine cornea.

Authors:  H M Brereton; S D Taylor; A Farrall; D Hocking; M A Thiel; M Tea; D J Coster; K A Williams
Journal:  Br J Ophthalmol       Date:  2005-09       Impact factor: 4.638

2.  The local vasoconstriction of infant's skin following instillation of mydriatic eye drops.

Authors:  Atilla Alpay; Bahri Ermis; Silay C Ugurbas; Fatih Battal; Haci Murat Sagdik
Journal:  Eur J Clin Pharmacol       Date:  2010-09-11       Impact factor: 2.953

3.  Effects of 0.5% apraclonidine on optic nerve head and peripapillary retinal blood flow.

Authors:  T W Kim; D M Kim
Journal:  Br J Ophthalmol       Date:  1997-12       Impact factor: 4.638

Review 4.  Brimonidine. A review of its pharmacological properties and clinical potential in the management of open-angle glaucoma and ocular hypertension.

Authors:  J C Adkins; J A Balfour
Journal:  Drugs Aging       Date:  1998-03       Impact factor: 3.923

5.  Apraclonidine and clonidine: a comparison of efficacy and side effects in normal and ocular hypertensive volunteers.

Authors:  N Yüksel; C Güler; Y Caglar; O Elibol
Journal:  Int Ophthalmol       Date:  1992-09       Impact factor: 2.031

6.  Ocular pharmacokinetic modeling using corneal absorption and desorption rates from in vitro permeation experiments with cultured corneal epithelial cells.

Authors:  Veli-Pekka Ranta; Mirka Laavola; Elisa Toropainen; Kati-Sisko Vellonen; Anu Talvitie; Arto Urtti
Journal:  Pharm Res       Date:  2003-09       Impact factor: 4.200

7.  [Transcorneal-paracorneal penetration route for topical application of drugs to the eyt. Mycophenolate mofetil as a model substance].

Authors:  E Bertelmann; S Knapp; P Rieck; S Keipert; C Hartmann; U Pleyer
Journal:  Ophthalmologe       Date:  2003-09       Impact factor: 1.059

8.  Efficacy of apraclonidine ophthalmic solution (Iopidine) in presumed silicon oil-induced glaucoma and primary open-angle glaucoma.

Authors:  E Gramer; S Busche; A Kampik; D Parsons
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-01       Impact factor: 3.117

9.  Topical tacrolimus nanocapsules eye drops for therapeutic effect enhancement in both anterior and posterior ocular inflammation models.

Authors:  Leslie Rebibo; Connie Tam; Yan Sun; Eve Shoshani; Amit Badihi; Taher Nassar; Simon Benita
Journal:  J Control Release       Date:  2021-03-30       Impact factor: 9.776

Review 10.  Peptidomimetics Therapeutics for Retinal Disease.

Authors:  Dylan E Parsons; Soo Hyeon Lee; Young Joo Sun; Gabriel Velez; Alexander G Bassuk; Mark Smith; Vinit B Mahajan
Journal:  Biomolecules       Date:  2021-02-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.